TITLE

Role of the GABAA Receptor in Anxiety: Evidence from animal models, molecular and clinical psychopharmacology, and brain imaging studies

AUTHOR(S)
Liberzon, Israel; Phan, K. L.; Khan, Samir; Abelson, James L.
PUB. DATE
September 2003
SOURCE
Current Neuropharmacology;Sep2003, Vol. 1 Issue 3, p267
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Several converging lines of evidence from molecular, animal, and clinical studies have demonstrated that the gamma-aminobutyric type A (GABAA) receptor complex plays a central role in the modulation of anxiety. While currently available therapeutic agents that act on this receptor (e.g., benzodiazepines) are effective anxiolytics, they are limited by side effects, tolerance, and abuse potential. Promising strategies to address these limitations include the development of subunit-selective agonists and partial agonists, which specifically ameliorate anxiety without causing sedation or motor impairment. In vivo neuroimaging studies have identified several limbic and paralimbic brain regions involved in the generation or modulation of anxiety and fear responses, suggesting that the neuroinhibitory processes of GABAA receptors may be localized in certain brain areas which may serve as specific sites for drug action. Indeed, neurochemical brain imaging studies have reported decreased ligand binding to GABAA benzodiazepine receptors in prefrontal and medial temporal cortex in a variety of anxiety disorders. This paper reviews recent findings from molecular neuropsychopharmacology and in vivo neuroimaging of GABAA benzodiazepine receptors which offer novel perspectives on the genesis of normal anxiety and on pathophysiology of anxiety disorders. Collectively, these findings suggest several potentially successful avenues for future development of GABAA receptor-mediated anxiolytic treatments, and prompt further exploration of this neurochemical system in pathogenesis of anxiety disorders.
ACCESSION #
11157169

Tags: GABA -- Receptors;  CELL receptors;  ANXIETY;  NEUROSES;  ANIMAL models in research;  PSYCHOPHARMACOLOGY

 

Related Articles

  • Medicinal Chemistry and Molecular Pharmacology of GABA-C Receptors. Johnston, Graham A.R. // Current Topics in Medicinal Chemistry;Aug2002, Vol. 2 Issue 8, p903 

    GABA-C receptors belong to the nicotinicoid superfamily of ionotropic receptors that include nicotinic acetylcholine receptors, bicuculline-sensitive GABA-A receptors, strychnine-sensitive glycine receptors and 5HT3 serotonin receptors. The GABA-C receptor concept arose from medicinal chemical...

  • Subunit Composition, Distribution and Function of GABA-A Receptor Subtypes. Sieghart, W.; Sperk, G. // Current Topics in Medicinal Chemistry;Aug2002, Vol. 2 Issue 8, p795 

    GABA-A receptors are the major inhibitory neurotransmitter receptors in the brain and are the site of action of many clinically important drugs. These receptors are composed of five subunits that can belong to eight different subunit classes. Depending on their subunit composition, these...

  • Animal models of anxiety disorders and stress. Campos, Alline C.; Fogaça, Manoela V.; Aguiar, Daniele C.; Guimarães, Francisco S. // Revista Brasileira de Psiquiatria;2013 Supplement 2, Vol. 35, pS101 

    Anxiety and stress-related disorders are severe psychiatric conditions that affect performance in daily tasks and represent a high cost to public health. The initial observation of Charles Darwin that animals and human beings share similar characteristics in the expression of emotion raise the...

  • �CCM but not physostigmine enhancement of memory retrieval depends on emotional processes in mice. Beracochea, Daniel; Celerier, Aurelie; Pierard, Christophe // Psychopharmacology;2004, Vol. 176 Issue 1, p66 

    Rationale: The effects of methyl beta-carbo-line-3-carboxylate (�CCM, an inverse agonists of GABA/ benzodiazepine receptors) or physostigmine (a cholinesterase inhibitor) on retrieval processes and relationships with anxiety have been only marginally studied. Objective: This study...

  • GABA-A Receptor Complex and Memory Processes. Chapouthier, Georges; Venault, Patrice // Current Topics in Medicinal Chemistry;Aug2002, Vol. 2 Issue 8, p841 

    Considerable evidence has been provided these last years for the involvement of the GABA-A receptor complex in memory processes. Compounds that enhance the action of GABA, such as benzodiazepines, impair memory processing. On the contrary, compounds that reduce the action of GABA, such as...

  • Preface. Dodd, Robert H. // Current Topics in Medicinal Chemistry;Aug2002, Vol. 2 Issue 8, p1l 

    Introduces the articles on gamma-aminobutyric acid (GABA) receptors, published in the August issue of the periodical 'Current Topics in Medicinal Chemistry.' Subunit composition of GABA receptor subtypes; Selective ligands for the GABA recognition site; Connection between memory and GABA...

  • Intra-median raphe nucleus (MRN) infusions of muscimol, a GABA-A receptor agonist, reinstate alcohol seeking in rats: role of impulsivity and reward. Anh L� Dzung; Funk, Douglas; Harding, Stephen; Juzytsch, Walter; Zhaoxia Li; Fletcher, Paul J. // Psychopharmacology;Jan2008, Vol. 195 Issue 4, p605 

    We previously found that the inhibition of median raphe nucleus (MRN) 5-HT transmission by local injections of a 5-HT1A agonist 8-OH-DPAT or corticotrophin-releasing factor (CRF) mimic the effect of foot shock stress to reinstate alcohol seeking. In this study, we further explored the role of...

  • GABAB-receptor subtypes assemble into functional heteromeric complexes. Kaupmann, Klemens; Malitschek, Barbara; Schuler, Valerie; Heid, Jakob; Froesti, Wolfgang; Beck, Pascal; Mosbacher, Johannes; Bischoff, Serge; Kulik, Akos; Shigemoto, Ryuichi; Karschin, Andreas; Bettler, Bernhard // Nature;12/17/1998, Vol. 396 Issue 6712, p683 

    Describes a gamma-aminobutyric acidB (GABAB) receptor subtype, GABABR2, which does not bind available GABAB antagonists with measurable potency. Evidence for the assembly of heteromeric GABAB receptors in vivo and the demonstration that GABABR2 and GABABR1a/b proteins immunoprecipitate and...

  • Picrotoxin in the medial prefrontal cortex impairs sensorimotor gating in rats: reversal by haloperidol. Japha, Kirsten; Koch, M. // Psychopharmacology;1999, Vol. 144 Issue 4, p347 

    Abstract Rationale: Neuropathological data indicate a GABAergic dysfunction in the prefrontal cortex and hippocampus of schizophrenics. On this basis, the construct validity of an animal model of schizophrenia was tested. Objective: This study assessed prepulse inhibition (PPI) of startle in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics